Why is fair value unavailable for Regenicin, Inc. (OTC-RGIN) stock?

A reliable fair value estimate is not currently available for Regenicin, Inc. (OTC-RGIN). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Regenicin, Inc.?

The current financial health read for Regenicin, Inc. (OTC-RGIN) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Regenicin, Inc. (OTC-RGIN) pay dividends?

The latest available data indicates no current dividend yield for Regenicin, Inc. (OTC-RGIN).

What is the market capitalization of Regenicin, Inc.?

The current market capitalization listed for Regenicin, Inc. is 0.153 K.

What is the ticker symbol for Regenicin, Inc.?

The ticker symbol for Regenicin, Inc. is OTC-RGIN, and the stock is listed on OTC Markets.

Where is Regenicin, Inc. (OTC-RGIN) listed?

Regenicin, Inc. (OTC-RGIN) is listed on OTC Markets.

Regenicin, Inc. (RGIN) Fair Value & Stock Analysis

Regenicin, Inc. (RGIN)

Regenicin, Inc. is a healthcare company focused on developing and commercializing tissue-engineered skin substitute technology. Its product portfolio includes NovaDerm, a multi-layered living skin and cultured skin substitute designed for burn treatment, and TempaDerm, which is intended for smaller wound areas such as ulcers. The company’s products are aimed at restoring characteristics of healthy human skin for use in treating burns, chronic wounds, and certain plastic surgery procedures. Founded in 2007 and based in Little Falls, New Jersey, the company adopted the Regenicin name in July 2010 after previously operating as Windstar, Inc. The common stock is listed on OTC Markets under the symbol RGIN.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-RGIN	Not available	Not available	Not available	Weak	0.0%	0.153 K